Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...

Improve your secondary battery manufacturing

SMC provides a large portfolio of products specially designed for secondary battery industry.

“You discover one thing – and then 10 new questions arise”

COVID-19, diabetes, heart disease, and the impact of dog ownership on humans are just some of multitasker Tove Fall’s areas of research. However, her current fo...

A new special edition and a new event in Copenhagen – This is happening at Life Science Sweden 2024

The new year brings new features for the readers of Life Science Sweden.

Lundabolag får brittiskt miljonbidrag för blodtest

Lundabolaget Prolight Diagnostics har fått ett statligt brittiskt bidrag på 17 miljoner kronor för fortsatt utveckling av ett blodtest som ska upptäcka eller ut...

Ready-to-install solutions for the lab-on-a-chip

Design for manufacturing lab-on-a-chip devices Reducing time-to-market together

Hon blir ny medicinsk chef på Synact Pharma

Synact Pharma, som bland annat utvecklar behandlingar för reumatiska sjukdomar, har utsett Kirsten Harting till ny Chief Medical Officer.

Han är ny på Capitainer

Solnaföretaget Capitainer har anställt Johan Olausson som applikationsspecialist.

The fast route to a safe insulin pen

Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...

Fast Optical Sectioning of Developing Organisms and Tissue Microstructures

ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.

Mizarra Business Management

Business Sweden’s new team is rolling out the blue-yellow carpet

According to Business Sweden’s life science team, the combination of substantial medical know-how and an ever-flourishing tech sector is a success factor for Sw...

Ännu ett Alzheimerläkemedel godkänt – lecanemab får konkurrens

Eli Lillys läkemedel donanemab mot Alzheimers godkändes på tisdagen av den amerikanska läkemedelsmyndigheten FDA. Det är det andra godkända bromsläkemedlet mot ...

SDS Life Science rekryterar erfaren IT-manager

Med sin expertis och erfarenhet som IT- arkitekt blir Jan Broman SDS-gruppens senaste tillskott i rollen som IT-manager.

Festo liquid dispensing: going fast and slow

Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs

Paolo Macchiarini in court – “The sole intent was to cure”

Paolo Macchiarini’s surgical procedure was illegal, life-threatening and caused severe and prolonged suffering to patients the prosecution claimed when the tria...

Small robots to deliver pharmaceuticals to the body

Robots that can operate inside the body and a platform that combines ultrasound with AI. These are a couple of the technologies that have qualified for a list t...

Michael J. Foxs stiftelse ger pengar till svenskt bolag

Göteborgsbaserade företaget Irlab får finansiering från skådespelaren Michael J. Foxs stiftelse. Pengarna ska gå till en klinisk fas I-studie med företagets läk...

Failed to read the fine print – lost his life’s work

A celebrated CEO and co-founder of a pioneering lab company one moment – the next, fired, kicked out and written out of the company’s history. This is the story...

CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”

When the first CAR-T therapies appeared, hopes were raised for the effective treatment for critically ill cancer patients. After a somewhat sluggish start, abou...

Ancient DNA provides new insights – “The immune system lost its job”

Ancient bone remains from our ancestors have provided new insights into the prevalence of multiple sclerosis. By looking back in time, researchers can provide a...

Lecanemab godkänns i Storbritannien – ”Viktigt steg för patienterna”

Det svenskutvecklade alzheimerläkemedlet Leqembi (lecanemab) beviljas marknadsföringstillstånd i Storbritannien. Men läkemedlet kommer inte att erbjudas inom de...

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Søren Bregenholt omvald som ordförande i MVA

Under Medicon Valley Alliance årsstämma fick styrelsen förnyat förtroende och valdes om.